个性化文献订阅>期刊> Expert opinion on investigational drugs
 

Polidocanol for endovenous microfoam sclerosant therapy

  作者 Eckmann, DM  
  选自 期刊  Expert opinion on investigational drugs;  卷期  2009年18-12;  页码  1919-1927  
  关联知识点  
 

[摘要]Background: Polidocanol is a liquid surfactant having endothelial cell lytic properties. in the form of a controlled, dispensed microfoam it is administered endovenously as a sclerosing agent in the treatment of varicose veins. Objective: This review summarizes efficacy of polidocanol endovenous microfoam sclerotherapy using a proprietary dispensing system to control foam characteristics and gas content for treating varicose veins. Methods: We reviewed in vitro, Phase I, Phase II and limited Phase III data for polidocanol microfoam with a focus on controlled foam formulation in therapy. Results/conclusions: Clinical trials of controlled dispensing of polidocanol microfoam provide evidence of effective treatment of chronic venous insufficiency with low toxicity, minimal risk and few complications.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内